Contributions of the compassionate care approach to psychedelic-assisted therapies in hospice and palliative care

Compassionate care is vital for psychedelic-assisted therapy (PAT) in hospice and palliative settings, as the patient-therapist bond strongly influences positive outcomes. The article reviews evidence for PAT's therapeutic potential in serious illness, defines compassion and compassionate care in healthcare, and links these to essential competencies for psychedelic therapists. It discusses how compassionate care can enhance PAT application in end-of-life contexts and presents implications for research and practice.

Study at a glance

Abstract

The scientific community's interest in psychedelic-assisted therapies (PAT) as a potential new therapeutic modality is growing, as evidence suggests that their use has a significant impact on the outcomes of patients with various conditions, including those with serious illnesses. In the context of PAT, the interpersonal bond established between patient and therapist is a vital factor for the positive results of this therapeutic approach. The aim of this article is to discuss the importance of these professionals adopting a compassionate care approach in the context of PAT in hospice and palliative care. This study starts with a brief review of the current literature on the therapeutic potential of PAT for people with serious diseases. Next, the definition of compassion and compassionate care in healthcare will be explored. Based on what the literature points out regarding the essential competencies for psychedelic therapists, it will address how compassionate care can contribute to the application of PAT in the hospice and palliative care context. Finally, the article will present implications for the research and practice of compassionate care in PAT, especially directed at people in hospice and palliative care.